Från fredagskvällen: Cereno Scientific meddelar positiva topline-resultat av Fas II-studien av ledande läkemedelskandidaten CS1 i pulmonell arteriell hypertension https://t.co/5bG2nzia3q
Read our QuickView on @Scandion Oncology ahead of Edison Open House: #Healthcare 2022, launching on 25 January.
Scandion Oncology is a #biotechnology company focused on the development of therapies to alleviate drug resistance in prevalent #cancers. $SCOL
https://t.co/eryOTvUtM8